Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

A patient with prescription benefits who is visiting a pharmacy may also be someone involved in the payer's decision process regarding a PBM. Or the patient may be an employer. Pharmacists can ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...

Pharmacy benefit managers received substantial attention ... parts of the healthcare system doesn’t stop with pharmacy and payer integration. Expansion into the supply chain side of the drug ...

Yet, perhaps the most significant healthcare reforms in the stopgap funding bill released late Tuesday are changes to how controversial middlemen in the drug supply chain, called pharmacy benefit ...

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to ...

Outcomes Matter Innovations, LLC ("OMI") today announced the addition of seasoned healthcare executive, Paul Marchetti, to ...